I invision the sachets as a "hard candy" more than a liquid source. My understanding of OM is that not one case is the same as far as location s in the mouth(I think my mother had it the late 1980's, though the term OM was never used, she defintely had painful mouth sores after chemo t-ments and her meals were most often soup form, apple sauce-nothing solid). I would think the rinse and spit would touch most, if not all, of the inflamed areas of the mouth. Is ipix working on the sachet on the premise that the sachet will disolve in the mouth into liquid form and then the patient swishes and spits? Or does the patient swallow the sachet and it's absorbed into the body which targets the OM?
My wish is the fda considers the ph2b B-OM results worthy of compassionate use(it is life threating at stage 4). There's a company in Europe called myTomorrows, started by a doctor whose father passed from lung cancer. There are American companies who are participating. Link below.
News 
Market Data 
Discover 
